Annual Drug Patent Expirations for ZETIA Zetia is a drug marketed by Organon and is included in one NDA. There are two patents protecting this drug and one Paragraph IV…
The post New patent expiration for Organon drug ZETIA appeared first on DrugPatent…
Annual Drug Patent Expirations for VELCADE Velcade is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from one supplier. There are two…
The post New patent expiration for Takeda Pharms drug VELCADE appeared first on Dru…
New patent expiration for Takeda Pharms drug VELCADE Read Post »
Annual Drug Patent Expirations for ADASUVE Adasuve is a drug marketed by Alexza Pharms and is included in one NDA. It is available from one supplier. There are seven patents…
The post New patent expiration for Alexza Pharms drug ADASUVE appeared first …
New patent expiration for Alexza Pharms drug ADASUVE Read Post »
Annual Drug Patent Expirations for WINLEVI Winlevi is a drug marketed by Sun Pharm and is included in one NDA. It is available from one supplier. There are eight patents…
The post New patent expiration for Sun Pharm drug WINLEVI appeared first on DrugP…
New patent expiration for Sun Pharm drug WINLEVI Read Post »
Annual Drug Patent Expirations for IXEMPRA+KIT Ixempra Kit is a drug marketed by R-pharm Us Llc and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for R-pharm Us drug IXEMPRA KIT appeared first on D…
New patent expiration for R-pharm Us drug IXEMPRA KIT Read Post »
Annual Drug Patent Expirations for SPIRIVA Spiriva is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from two suppliers. There are sixteen patents…
The post New patent expiration for Boehringer Ingelheim drug SPIRI…
New patent expiration for Boehringer Ingelheim drug SPIRIVA Read Post »
LEQVIO (inclisiran sodium) Novartis Patent: 10,590,418 Expiration: Jul 19, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug Pa…
Drug Patent Expirations for the Week of July 17, 2022 Read Post »
Annual Drug Patent Expirations for VARITHENA Varithena is a drug marketed by Provensis and is included in one NDA. It is available from one supplier. There are five patents protecting…
The post New patent expiration for Provensis drug VARITHENA appeare…
New patent expiration for Provensis drug VARITHENA Read Post »
Annual Drug Patent Expirations for LEQVIO Leqvio is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are nineteen patents protecting…
The post New patent expiration for Novartis drug LEQVIO appeared first…
Annual Drug Patent Expirations for AXID Axid is a drug marketed by Smithkline Beecham, Braintree, and Glaxosmithkline and, and is included in three NDAs. There is one patent protecting this…
The post New patent expiration for Braintree drug AXID appear…